Journal of Infection
Volume 64, Issue 2 , Pages 148-155 , February 2012

A systematic review of bacteremias in cellulitis and erysipelas

  • Craig G. Gunderson

      Affiliations

    • Department of Internal Medicine and VA Connecticut Health Care System, Yale School of Medicine, 950 Campbell Avenue, West Haven CT 06516, USA
    • Veterans Health Administration, Public Health, 950 Campbell Avenue, West Haven CT 06516, USA
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine and VA Connecticut Health Care System, Yale School of Medicine, 950 Campbell Avenue, West Haven CT 06516, USA. Tel.: +1 2039325711x2616; fax: +1 2039373425.
    • ,
  • Richard A. Martinello

      Affiliations

    • Department of Internal Medicine and VA Connecticut Health Care System, Yale School of Medicine, 950 Campbell Avenue, West Haven CT 06516, USA
    • Department of Pediatrics, Yale School of Medicine, 950 Campbell Avenue, West Haven CT 06516, USA
    • Veterans Health Administration, Public Health, 950 Campbell Avenue, West Haven CT 06516, USA

,Accepted 4 November 2011.

References 

  1. Swartz MN. Clinical practice. Cellulitis. N Engl J Med. Feb 26, 2004;350(9):904–912
  2. Stevenson A, Hider P, Than M. The utility of blood cultures in the management of non-facial cellulitis appears to be low. N Z Med J. Mar 11, 2005;118(1211):U1351
  3. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. Jan 25, 1996;334(4):240–245
  4. Swartz MN. Skin and soft tissue infections. In:  Mandell GL,  Bennett JE,  Dolin R editor. 5th ed.. Principles and practice of infectious diseases. vol 1:Philadelphia: Churchill Livingstone; 2000;p. 1037–1057
  5. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. Nov 15, 2005;41(10):1373–1406
  6. Klein E, Smith DL, Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999–2006. Emerg Infect Dis. Dec 2009;15(12):1925–1930
  7. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis. Jan 2007;57(1):7–13
  8. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. Mar 7, 2006;144(5):309–317
  9. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. Aug 17, 2006;355(7):666–674
  10. Gupta K, Macintyre A, Vanasse G, Dembry LM. Trends in prescribing beta-lactam antibiotics for treatment of community-associated methicillin-resistant Staphylococcus aureus infections. J Clin Microbiol. Dec 2007;45(12):3930–3934
  11. Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clin Infect Dis. Oct 15, 2010;51(8):895–903
  12. Gorwitz RJ. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. Mar 15, 2007;44(6):785–787
  13. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. Feb 2011;52(3):e18–e55
  14. Figtree M, Konecny P, Jennings Z, Goh C, Krilis SA, Miyakis S. Risk stratification and outcome of cellulitis admitted to hospital. J Infect. Jun 2010;60(6):431–439
  15. Lazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect. Dec 2005;51(5):383–389
  16. Stevens DL, Eron LL. Cellulitis and soft-tissue infections. Ann Intern Med. Jan 6, 2009;150(1):ITC11
  17. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. Jul 26, 2007;357(4):380–390
  18. Chira S, Miller LG. Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review. Epidemiol Infect. Mar 2010;138(3):313–317
  19. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. May 1, 2010;375(9725):1557–1568
  20. Moellering RC. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. Apr 1, 2008;46(7):1032–1037
  21. Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore). Jul 2010;89(4):217–226
  22. Horowitz Y, Sperber AD, Almog Y. Gram-negative cellulitis complicating cirrhosis. Mayo Clin Proc. Feb 2004;79(2):247–250
  23. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. Oct 1, 2004;39(7):885–910
  24. Siljander T, Karppelin M, Vahakuopus S, et al. Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis. Mar 15, 2008;46(6):855–861
  25. Bjornsdottir S, Gottfredsson M, Thorisdottir AS, et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis. Nov 15, 2005;41(10):1416–1422
  26. Bergkvist PI, Sjobeck K. Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. Scand J Infect Dis. 1997;29(4):377–382
  27. Bishara J, Golan-Cohen A, Robenshtok E, Leibovici L, Pitlik S. Antibiotic use in patients with erysipelas: a retrospective study. Isr Med Assoc J. Oct 2001;3(10):722–724
  28. Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis. Nov 1996;23(5):1091–1098
  29. Jorup-Ronstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis. 1986;18(6):519–524
  30. Masmoudi A, Maaloul I, Turki H, et al. Erysipelas after breast cancer treatment (26 cases). Dermatol Online J. 2005;11(3):12
  31. Bernard P, Bedane C, Mounier M, Denis F, Catanzano G, Bonnetblanc JM. Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol. Jun 1989;125(6):779–782
  32. Figtree M, Konecny P, Jennings Z, Goh C, Krilis SA, Miyakis S. Risk stratification and outcome of cellulitis admitted to hospital. J Infect. Jun 2010;60(6):431–439
  33. Siljander T, Karppelin M, Vahakuopus S, et al. Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis. Mar 15, 2008;46(6):855–861
  34. Baddour LM, Bisno AL. Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs. JAMA. Feb 24, 1984;251(8):1049–1052
  35. Bjornsdottir S, Gottfredsson M, Thorisdottir AS, et al. Risk factors for acute cellulitis of the lower limb: a prospective case–control study. Clin Infect Dis. Nov 15, 2005;41(10):1416–1422
  36. Goldgeier MH. The microbial evaluation of acute cellulitis. Cutis. Jun 1983;31(6):649–650
  37. Ho PW, Pien FD, Hamburg D. Value of cultures in patients with acute cellulitis. South Med J. Nov 1979;72(11):1402–1403
  38. Hook EW, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. Feb 1986;146(2):295–297
  39. Kielhofner MA, Brown B, Dall L. Influence of underlying disease process on the utility of cellulitis needle aspirates. Arch Intern Med. Nov 1988;148(11):2451–2452
  40. Kulthanan K, Rongrungruang Y, Siriporn A, et al. Clinical and microbiologic findings in cellulitis in Thai patients. J Med Assoc Thai. Jun 1999;82(6):587–592
  41. Lentino JR, Stachowski M, Strikas R, Parrillo P. Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections. Antimicrob Agents Chemother. Jun 1984;25(6):778–780
  42. Liles DK, Dall LH. Needle aspiration for diagnosis of cellulitis. Cutis. Jul 1985;36(1):63–64
  43. Lutomski DM, Trott AT, Runyon JM, Miyagawa CI, Staneck JL, Rivera JO. Microbiology of adult cellulitis. J Fam Pract. Jan 1988;26(1):45–48
  44. Peralta G, Padron E, Roiz MP, et al. Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis. Oct 2006;25(10):619–626
  45. Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis. Dec 1999;29(6):1483–1488
  46. Rescigno J, McCormick B, Brown AE, Myskowski PL. Breast cellulitis after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. Apr 30, 1994;29(1):163–168
  47. Sachs MK. The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults [Erratum appears in Arch Intern Med 1991 Feb;151(2):244]. Arch Intern Med. Sep 1990;150(9):1907–1912
  48. Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med. Nov 1992;93(5):543–548
  49. Stalnikowicz R, Block C. The yield of blood cultures in a department of emergency medicine. Eur J Emerg Med. Jun 2001;8(2):93–97
  50. Woo PC, Lum PN, Wong SS, Cheng VC, Yuen KY. Cellulitis complicating lymphoedema. Eur J Clin Microbiol Infect Dis. Apr 2000;19(4):294–297

PII: S0163-4453(11)00551-2

doi: 10.1016/j.jinf.2011.11.004

Journal of Infection
Volume 64, Issue 2 , Pages 148-155 , February 2012

Article Tools

* Image Usage & Resolution